We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Unilever PLC | NYSE:UL | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.31 | 0.59% | 52.46 | 1,596 | 09:05:06 |
By Robb M. Stewart
Unilever PLC's U.S.-listed stock retreated Tuesday as investors reacted to the company's efforts to push further into health, beauty and hygiene products with a $68 billion approach for GlaxoSmithKline PLC's consumer-health business.
In morning trading, the American depositary receipts were 11% lower at $48.41. They now stand down 10% in the new year, and 19% weaker over the last 12 months.
The maker of Dove soap and Ben & Jerry's ice cream over the weekend said it made a takeover approach for the business, which is 68% owned by Glaxo and 32% by Pfizer Inc. If successful, it would be Unilever's biggest-ever acquisition and the company said it would be accompanied by significant divestitures as it looks to shift its portfolio toward higher-growth categories.
Fitch Ratings on Tuesday cautioned an acquisition of the consumer-health business is likely to raise Unilever's debt to a level the company wouldn't be able to reduce it sufficiently to maintain an A rating category over 2024-2025, which could open the door to a multi-notch downgrade into the BBB category. Fitch said it believes Unilever's offer would need to be raised to be successful, given Glaxo's refusal to consider it, resulting in a further deterioration of the company's expected credit metrics.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
January 18, 2022 10:41 ET (15:41 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Unilever Chart |
1 Month Unilever Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions